Immunotherapy

Review Article

Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors
Dongsheng He,Rilan Bai,Naifei Chen,Jiuwei Cui
Pages: 421-441 HTML
Hypoxic tumor microenvironment: Destroyer of natural killer cell function
Yongfei Zhang,Feifei Guo,Yufeng Wang
Pages: 138-150 HTML
New roles of tumor-derived exosomes in tumor microenvironment
Shiqian Chen,Jinzhe Sun,Huan Zhou,Hongbin Lei,Dan Zang,Jun Chen
Pages: 151-166 HTML
Manufacturing CAR-NK against tumors: Who is the ideal supplier?
Feifei Guo,Yi Zhang,Jiuwei Cui
Pages: 1-16 HTML
Immune evasion and therapeutic opportunities based on natural killer cells
Jinjin Zhang,Feifei Guo,Lingyu Li,Songling Zhang,Yufeng Wang
Pages: 283-298 HTML
Mn-based cGAS-STING activation for tumor therapy
Aiping Huang,Wenhu Zhou
Pages: 19-43 HTML
When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road
Yufeng Gu,Shengjun Xu,Zhengxin Wang,Jiayin Yang,Shusen Zheng,Qiang Wei,Zhikun Liu,Xiao Xu
Pages: 92-107 HTML
Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics
Xiaojing Chu,Yu Zhang,Sijin Cheng
Pages: 543-553 HTML
Myeloid checkpoints for cancer immunotherapy
Yixin Qian,Ting Yang,Huan Liang,Mi Deng
Pages: 460-482 HTML
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors
Beibei Pei,Xiaoyan Ma,Na Wu,Chen Wang,Wenhui Yang
Pages: 252-265 HTML
Inducing immunogenic cell death in immuno-oncological therapies
Dongdong Ti,Xin Yan,Jianshu Wei,Zhiqiang Wu,Yao Wang,Weidong Han
Pages: 1-10 HTML

Original Article

PTPRD/PTPRT mutation correlates to treatment outcomes of immunotherapy and immune landscape in pan-cancers
Gangjian Wang,Xin Ji,Haojie Wang,Xiaohuan Tang,Xiaofang Xing,Jiafu Ji
Pages: 316-330 HTML
Th1 cells inducing IFNγ response improves immunotherapy efficacy in gastric cancer
Qi Cao,Ruidong Xue,Ning Zhang
Pages: 299-315 HTML

Perspective

Predictive value of co-expression patterns of immune checkpoint molecules for clinical outcomes of hematological malignancies
Cunte Chen,Yangqiu Li
Pages: 245-251 HTML
Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors
Shasha Liu,Yi Zhang
Pages: 239-244 HTML

Commentary

Pan-cancer tumor-infiltrating T cells: A great hallmark in cancer immunology research
Anqiang Wang,Zhaode Bu
Pages: 115-116 HTML